EASL Congress 2024: Selected coverage on viral hepatitis

Back to the "HIV and Co-Infections News" list

The European Association for the Study of the Liver (EASL) Congress was held in Milan, Italy on 5-8 June 2024. Check out the official website of the Congress.

Here is selected coverage on viral hepatitis:

Hepatitis B:

Hepatitis D:

          — SEE ALSO: Healio: VIDEO: Bulevirtide plus PEG-IFN a-2a potentially ‘viable finite therapy’ for chronic HDV

          — SEE ALSO: MedPage Today: Bulevirtide/pegylated interferon combo beats monotherapy for chronic hepatitis D

Hepatitis C:

         — SEE ALSO: Contagion Live: Investigational HCV therapy shows a 97% sustained virologic response rate


Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?


Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.